Beijing SDL Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001FJ3
CNY
10.36
0.09 (0.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Positive results in Mar 25

  • PRE-TAX PROFIT(Q) At CNY 20.2 MM has Grown at 1,308.71%
  • NET PROFIT(Q) At CNY 10.07 MM has Grown at 257.2%
  • RAW MATERIAL COST(Y) Fallen by -12.66% (YoY)
2

With ROE of 7.38%, it has a fair valuation with a 1.06 Price to Book Value

3

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 3,044 Million (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.81%

stock-summary
Debt Equity

-0.57

stock-summary
Return on Equity

8.11%

stock-summary
Price to Book

1.17

Revenue and Profits:
Net Sales:
292 Million
(Quarterly Results - Sep 2025)
Net Profit:
53 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.89%
0%
20.89%
6 Months
29.66%
0%
29.66%
1 Year
59.63%
0%
59.63%
2 Years
100.78%
0%
100.78%
3 Years
10.45%
0%
10.45%
4 Years
32.14%
0%
32.14%
5 Years
116.28%
0%
116.28%

Beijing SDL Technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.49%
EBIT Growth (5y)
23.43%
EBIT to Interest (avg)
39.08
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.55
Sales to Capital Employed (avg)
0.55
Tax Ratio
15.26%
Dividend Payout Ratio
92.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.17%
ROE (avg)
8.40%

Valuation key factors

Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.06
EV to EBIT
7.58
EV to EBITDA
6.16
EV to Capital Employed
1.13
EV to Sales
0.91
PEG Ratio
1.67
Dividend Yield
3.23%
ROCE (Latest)
14.94%
ROE (Latest)
7.38%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 12.17% vs -15.97% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 100.00% vs -33.42% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "292.20",
          "val2": "260.50",
          "chgp": "12.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.00",
          "val2": "16.90",
          "chgp": "77.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "53.40",
          "val2": "26.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "102.60%",
          "val2": "26.90%",
          "chgp": "7.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.94% vs 0.32% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -16.33% vs -28.58% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,412.10",
          "val2": "1,501.20",
          "chgp": "-5.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "202.50",
          "val2": "217.30",
          "chgp": "-6.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "20.30",
          "chgp": "-91.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.40",
          "val2": "-0.60",
          "chgp": "-1,633.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "169.60",
          "val2": "202.70",
          "chgp": "-16.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "115.10%",
          "val2": "117.40%",
          "chgp": "-0.23%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
292.20
260.50
12.17%
Operating Profit (PBDIT) excl Other Income
30.00
16.90
77.51%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
53.40
26.70
100.00%
Operating Profit Margin (Excl OI)
102.60%
26.90%
7.57%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 12.17% vs -15.97% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 100.00% vs -33.42% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
1,412.10
1,501.20
-5.94%
Operating Profit (PBDIT) excl Other Income
202.50
217.30
-6.81%
Interest
1.70
20.30
-91.63%
Exceptional Items
-10.40
-0.60
-1,633.33%
Consolidate Net Profit
169.60
202.70
-16.33%
Operating Profit Margin (Excl OI)
115.10%
117.40%
-0.23%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -5.94% vs 0.32% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -16.33% vs -28.58% in Dec 2023

stock-summaryCompany CV
About Beijing SDL Technology Co., Ltd. stock-summary
stock-summary
Beijing SDL Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available